A study combining patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers has highlighted the importance of combining information including genetics for prediction of MCI to AD progression [35], as has already been shown in cardiovascular disease [10]. Here, APOE is linked to Alzheimer disease.